Chapter 2

Treating the “Young at Heart”: Management of Heart Failure in the Older Population

Tuck Yean Yong and Kareeann Sok Fun Khow

Abstract

The prevalence of heart failure rises with increasing age. Although patients with heart failure are mainly elderly (age ≥65 years), evidence for efficacious diagnostic and therapeutic approaches are limited in this population. Diagnosis of heart failure in older people is challenging because of comorbidities masking symptoms and signs; different diagnostic cut-offs of natriuretic peptides; and the high prevalence of heart failure with preserved ejection fraction (HFPEF). Geriatric syndromes (such as cognitive impairment, frailty, falls and incontinence) are common in heart failure and can affect patients’ prognosis. In older patients with reduced ejection fraction, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and betablockers have improved clinical outcomes. However no therapeutic strategy has yet been found to improve prognosis of HFPEF which affect many older people.

Total Pages: 17-33 (17)

Purchase Chapter  Book Details

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.